Women & Gender

{Photo credit: Glenn Ruga}Photo credit: Glenn Ruga

Management Sciences for Health (MSH) is pleased to announce the availability of the 2014 edition of the International Drug Price Indicator Guide. The Guide provides a spectrum of prices from 25 sources, including pharmaceutical suppliers, international development organizations, and government agencies.

Use the Guide to determine the probable cost of pharmaceutical products for programs, compare current prices paid to prices available on the international market, assess the potential financial impact of changes to a medicines list, and to support rational medicine use education.

[2014 Edition of the International Drug Price Guide]2014 Edition of the International Drug Price GuideThe 2014 edition of the Guide includes almost 40 new items and has prices for more than 1,100 products. The therapeutic classes with the most new entries this year are anti-tuberculosis medicines, cytotoxics, and diagnostics. (Note: It is called the 2014 edition because the prices in it are from 2014.)

{Photo credit: Katy Doyle/MSH, West Africa}Photo credit: Katy Doyle/MSH, West Africa

The following blog post is a web-formatted version of MSH's Global Health Impact newsletter (June 2015 edition), Good Governance Strengthens Health Systems. We welcome your questions and feedback in the comments. Get Global Health Impact in your inbox

Notes

by James A. Rice, PhD

What do we mean by governance? Governance is a structured process used by a group of people—often referred to as a governing body, board, or council—to make decisions about policy, plans, and rules of collective action for an organization or system. For health organizations, the focus of this collective action is strengthening health systems to expand access to quality health services and achieve sustainable gains in health outcomes.

{Photo credit: Rui Pires}Photo credit: Rui Pires

While at the World Federation of Public Health Associations meeting in India earlier this year, I met with a district health manager from Nigeria. He asked,

What is the value of having a District Health Council? It takes a lot of time to work with them; so what is the return on that invested time?

My Nigerian colleague is not the only one struggling to support the role of governing bodies. For years, governing bodies -– from district and provincial health councils to executive boards -– have been overlooked as valuable players in strengthening health systems.

“There are many examples of how investments in good governance lead to better health outcomes,” I said, “and many opportunities for supporting the under-supported leaders who govern through district health councils, hospital boards, or other governing bodies.”

We talked about how in the journey to stronger health system performance and greater health outcomes, it is not enough to have good leaders and managers to enable the talents of good health workers.

Strong health systems also need strong trustees serving on the organization’s governing body.

We determined that a good district health council -– or any good governing body –- amplifies the investment of time in at least three ways:

 {Photo credit: MSH staff}A woman and child visit an accredited dispenser in Tanzania.Photo credit: MSH staff

There are ways to make informal outlets fit for quality care in poor areas, say Jafary Hassan Liana and Martha Embrey.

{Photo credit: MSH staff/Haiti}Photo credit: MSH staff/Haiti

Multisector perspectives on achieving resilience in global health

Recent events, such as the Haiti and Nepal earthquakes and West Africa Ebola outbreak, have demonstrated, now more than ever, that a resilient health system is vital to ensuring stability and well-being in society. With this in mind, Management Sciences for Health (MSH) and the USAID-funded, MSH-led, Leadership, Management, and Governance project in Haiti (LMG/Haiti), partnered with Johnson & Johnson to host a high-level panel event during the 68th session of the World Health Assembly (WHA) in Geneva, Switzerland.

The event, entitled Building and Maintaining Resilience to Address Global Health Challenges, examined how the global health community can move beyond typical public-private partnerships to achieve a model of true country stakeholder engagement. This model would include and leverage the strengths of all actors to build systems capable of addressing long-term global health issues like non-communicable diseases while maintaining resilience to outbreaks like Ebola.

 {Management Sciences for Health and Novo Nordisk}Save Lives of Women & Newborns through Gestational Diabetes Screening: A Call to Action (Postcard: front)Management Sciences for Health and Novo Nordisk

Detecting and treating diabetes in pregnancy offers a simple, low-cost opportunity to improve maternal and child health and reduce maternal deaths. Yet, it has received scant attention as a public health priority, especially in low- and middle-income countries.

To put gestational diabetes on the global development agenda and call for action, Management Sciences for Health (MSH) and Novo Nordisk sponsored a technical advocacy event on the sidelines of the 68th World Health Assembly (WHA) in Geneva that closely examined gestational diabetes mellitus (GDM) and featured case studies and lessons learned from Ethiopia and Colombia.

[Catharine Howard Taylor, MSH Vice President, Center for Health Services, gives an overview of gestational diabetes and the need for routine screening to open the conversation.] {Photo credit: Barbara Ayotte/MSH}Catharine Howard Taylor, MSH Vice President, Center for Health Services, gives an overview of gestational diabetes and the need for routine screening to open the conversation.Photo credit: Barbara Ayotte/MSH

{Photo credit: Warren Zelman.}Photo credit: Warren Zelman.

MSH's May 2015 newsletter highlights the global health impact of pharmaceutical management: Ensuring access to affordable, quality medicines saves lives (subscribe).

Introduction

by Jonathan D. Quick, MD, MPH

Health care is largely dependent upon essential medicines for preventing infection, reducing pain, and treating illness. The development of effective medicines, however, is only the beginning.

Quality care means getting the right medicine, in the right dose, at an affordable price, for all the people who need it.

Accessible, affordable, and properly used medicines save lives. Major childhood killers like diarrhea, pneumonia, malaria, and even HIV, are preventable or treatable with essential medicines. But for many children, where they live means the difference between life and death: some 30,000 children in developing countries die every year from diseases treatable with basic essential medicines.

Chryste D. Best recently was named one of the top 300 women in global Health. Best establishes the processes, procedures, and controls to ensure that all products procured and supplied by the Supply Chain Management System (SCMS) meet appropriate quality standards.

We spoke with MSH’s Chryste D. Best, BS, product quality assurance manager, The Partnership for Supply Chain Management (PFSCM), about her selection as one of the top 300 women leaders in global health by the Global Health Programme of the Graduate Institute of International and Development Studies in Geneva. Best provides innovative quality assurance oversight for the global procurement of medicines and commodities by MSH and partners.

{Photo: Gwenn Dubourthoumieu}Photo: Gwenn Dubourthoumieu

The Partnership for Supply Chain Management (PFSCM), an organization formed through a partnership between Management Sciences for Health (MSH) and John Snow Research & Training Institute, Inc., (JSI R&T), uses an innovative consortium model that draws on the capabilities and experience of 13 internationally-renowned organizations. PFSCM harnesses this expertise to strengthen, develop and manage secure, reliable, cost-effective and sustainable supply chains to meet the needs of health care and other public services. Since 2009, PFSCM has leveraged this unique expertise to manage the Pooled Procurement Mechanism (PPM), previously known as Voluntary Pooled Procurement (VPP).

Funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), PPM procures and delivers about $46.6 million in life-saving health care products monthly, including HIV and malaria medicines, test kits, and related commodities. As a managing partner in PPM, MSH has played a key role in the mechanism’s overall management and strategy.

{Photo credit: Rui Pires}Photo credit: Rui Pires

More than 10 years ago, Management Sciences for Health (MSH) developed its Leadership Development Program (LDP), a structured program for leadership development that ties together personal development and real life challenges, utilizing a team-based, action learning approach to improve health outcomes.

This week, May 26 through May 28, all health leaders and managers interested in the LDP, and the new and improved LDP Plus (LDP+), are invited to participate in a free, three-day online seminar on MSH’s LeaderNet.

Pages

Printer Friendly Version
Subscribe to RSS - Women & Gender